SCHEMBL25219643

SCHEMBL25219643

O=C([O-])c1ccnc(-c2cc(C(=O)[O-])ccn2)c1.[Ni+2]

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM5C P41229 12/20 0.61
KDM2A Q9Y2K7 8/20 0.61
KDM3A Q9Y4C1 8/20 0.61
KDM4A O75164 8/20 0.61
KDM4C Q9H3R0 7/20 0.61
KDM4E B2RXH2 7/20 0.61
KDM6B O15054 4/20 0.52
P4HA1 P13674 1/20 0.50
KDM4B O94953 5/20 0.47
KDM5B Q9UGL1 5/20 0.47
JMJD6 Q6NYC1 2/20 0.46
P4HTM Q9NXG6 1/20 0.44
CA2 P00918 1/20 0.43
CA4 P22748 1/20 0.43
KMO O15229 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28374030 0.98 KDM5C (0.63) KDM5CKDM2AKDM3AKDM4AKDM4C
SCHEMBL15401893 0.96 KDM5C (0.61) KDM5CKDM2AKDM3AKDM4AKDM4C
SCHEMBL2187195 0.96 KDM5C (0.61) KDM5CKDM2AKDM3AKDM4AKDM4C
SCHEMBL528024 0.96 KDM5C (0.61) KDM5CKDM2AKDM3AKDM4AKDM4C
Lithium Ion SCHEMBL25269674 0.96 KDM5C (0.61) KDM5CKDM2AKDM3AKDM4AKDM4C
SCHEMBL25273098 0.96 KDM5C (0.61) KDM5CKDM2AKDM3AKDM4AKDM4C
Potassium Ion SCHEMBL25270943 0.96 KDM5C (0.66) KDM5CKDM2AKDM3AKDM4AKDM4C
SCHEMBL25222959 0.96 KDM5C (0.61) KDM5CKDM2AKDM3AKDM4AKDM4C
SCHEMBL8154522 0.96 KDM5C (0.61) KDM5CKDM2AKDM3AKDM4AKDM4C
SCHEMBL4848322 0.96 KDM5C (0.61) KDM5CKDM2AKDM3AKDM4AKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240322260-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS CONTAINING THE SAME CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2024-09-26 US claimed
EP-4318701-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS COMPRISING SAME Contemporary Amperex Technology Co., Limited (CN) 2024-02-07 EP claimed
US-20240322260-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS CONTAINING THE SAME CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2024-09-26 US disclosed
EP-4318701-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS COMPRISING SAME Contemporary Amperex Technology Co., Limited (CN) 2024-02-07 EP disclosed
WO-2023102793-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS COMPRISING SAME 宁德时代新能源科技股份有限公司 2023-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240322260-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS CONTAINING THE SAME SOD1, SOD3, CAT KDM5C 4733/4885KDM2A 4156/4885KDM3A 4351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.